Cargando…

Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0

CONTEXT: Hepatitis C virus (HCV) genotyping at our institution is performed using the Versant HCV genotype 2.0 Line Probe Assay (LiPA). The last steps of this procedure are manual, laborious, and error-prone process that involves the comparison of the banding pattern on a test strip to a physical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Dussaq, Alex M., Soni, Abha, Willey, Christopher, Park, Seung L., Harada, Shuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653960/
https://www.ncbi.nlm.nih.gov/pubmed/29114435
http://dx.doi.org/10.4103/jpi.jpi_44_17
_version_ 1783273314176729088
author Dussaq, Alex M.
Soni, Abha
Willey, Christopher
Park, Seung L.
Harada, Shuko
author_facet Dussaq, Alex M.
Soni, Abha
Willey, Christopher
Park, Seung L.
Harada, Shuko
author_sort Dussaq, Alex M.
collection PubMed
description CONTEXT: Hepatitis C virus (HCV) genotyping at our institution is performed using the Versant HCV genotype 2.0 Line Probe Assay (LiPA). The last steps of this procedure are manual, laborious, and error-prone process that involves the comparison of the banding pattern on a test strip to a physical reference table. AIM: We developed a web-based HCV genotype interpretation platform that utilizes a scanned image to generate the genotypes, thus minimizing interpretation time and reducing error. SUBJECTS AND METHODS: HCV Genie 2 utilizes a database of banding patterns in conjuncture with image analysis algorithms to determine the genotype for any number of scanned LiPA strips. HCV Genie 2 is built with client-side JavaScript; allowing the program to run in the user' browser rather than on an unknown server, essentially eliminating data and patient privacy concerns. RESULTS: HCV Genie 2 was tested over 2 months and proved identical to human expert interpretation for 148 samples (>1000 bands identified). Manual intervention was required only for two faint bands and one false-positive band; this was done utilizing the built-in-user interface. Utilizing the original method, the trained laboratory technician interpretation time for 16 samples was 13.8 (±0.96) min as compared to 5.0 (±1.09) min with HCV Genie 2, a 63.8% decrease. In addition to the time savings, the new method provides an additional validation step, which decreases the potential for errors. CONCLUSIONS: Our institution has moved exclusively to utilize the new techniques and tools described here. Both experienced technicians and the molecular pathologists at our institution prefer the workflow using HCV Genie. It is easier for the technicians to prepare and document, and the pathologists are more rapidly able to review and confirm results. The use of this tool will lead to increase the quality of patient care delivered through this test methodology by decreasing the potential for error. The algorithms developed here can be ported to similar band identification platforms, most directly to other LiPAs.
format Online
Article
Text
id pubmed-5653960
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56539602017-11-07 Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0 Dussaq, Alex M. Soni, Abha Willey, Christopher Park, Seung L. Harada, Shuko J Pathol Inform Original Article CONTEXT: Hepatitis C virus (HCV) genotyping at our institution is performed using the Versant HCV genotype 2.0 Line Probe Assay (LiPA). The last steps of this procedure are manual, laborious, and error-prone process that involves the comparison of the banding pattern on a test strip to a physical reference table. AIM: We developed a web-based HCV genotype interpretation platform that utilizes a scanned image to generate the genotypes, thus minimizing interpretation time and reducing error. SUBJECTS AND METHODS: HCV Genie 2 utilizes a database of banding patterns in conjuncture with image analysis algorithms to determine the genotype for any number of scanned LiPA strips. HCV Genie 2 is built with client-side JavaScript; allowing the program to run in the user' browser rather than on an unknown server, essentially eliminating data and patient privacy concerns. RESULTS: HCV Genie 2 was tested over 2 months and proved identical to human expert interpretation for 148 samples (>1000 bands identified). Manual intervention was required only for two faint bands and one false-positive band; this was done utilizing the built-in-user interface. Utilizing the original method, the trained laboratory technician interpretation time for 16 samples was 13.8 (±0.96) min as compared to 5.0 (±1.09) min with HCV Genie 2, a 63.8% decrease. In addition to the time savings, the new method provides an additional validation step, which decreases the potential for errors. CONCLUSIONS: Our institution has moved exclusively to utilize the new techniques and tools described here. Both experienced technicians and the molecular pathologists at our institution prefer the workflow using HCV Genie. It is easier for the technicians to prepare and document, and the pathologists are more rapidly able to review and confirm results. The use of this tool will lead to increase the quality of patient care delivered through this test methodology by decreasing the potential for error. The algorithms developed here can be ported to similar band identification platforms, most directly to other LiPAs. Medknow Publications & Media Pvt Ltd 2017-10-03 /pmc/articles/PMC5653960/ /pubmed/29114435 http://dx.doi.org/10.4103/jpi.jpi_44_17 Text en Copyright: © 2017 Journal of Pathology Informatics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Dussaq, Alex M.
Soni, Abha
Willey, Christopher
Park, Seung L.
Harada, Shuko
Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title_full Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title_fullStr Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title_full_unstemmed Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title_short Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0
title_sort hepatitis c virus genie: a web 2.0 interpretation and analytics platform for the versant hepatitis c virus genotype line probe assay version 2.0
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653960/
https://www.ncbi.nlm.nih.gov/pubmed/29114435
http://dx.doi.org/10.4103/jpi.jpi_44_17
work_keys_str_mv AT dussaqalexm hepatitiscvirusgenieaweb20interpretationandanalyticsplatformfortheversanthepatitiscvirusgenotypelineprobeassayversion20
AT soniabha hepatitiscvirusgenieaweb20interpretationandanalyticsplatformfortheversanthepatitiscvirusgenotypelineprobeassayversion20
AT willeychristopher hepatitiscvirusgenieaweb20interpretationandanalyticsplatformfortheversanthepatitiscvirusgenotypelineprobeassayversion20
AT parkseungl hepatitiscvirusgenieaweb20interpretationandanalyticsplatformfortheversanthepatitiscvirusgenotypelineprobeassayversion20
AT haradashuko hepatitiscvirusgenieaweb20interpretationandanalyticsplatformfortheversanthepatitiscvirusgenotypelineprobeassayversion20